record state
frontier-ownedReview status
This finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
unreviewed
frontiers / frontier
Finding bundle
back to stateno incoming links yet
record state
frontier-ownedThis finding is part of accepted frontier state. Review events, reviewable changes, and proof state explain how it can change.
finding statement
finding type[object Object] · [object Object] · [object Object] · [object Object] · [object Object] · [object Object]
evidence
source-boundexperimental · manual state transition; placebo-controlled clinical trial where source reports control arm · Homo sapiens
proof impact
packet context1 reviewable changes and 0 evaluation records are attached to this finding id.
Evidence and conditions
method
manual state transition; placebo-controlled clinical trial where source reports control arm
evidence type
experimental
species
Homo sapiens
evidence spans
Gantenerumab subcutaneous dosing reduces brain amyloid in prodromal AD in a dose-dependent manner; a Phase II extension study demonstrated near-complete amyloid clearance at higher doses, informing the dose selection for the Phase III trials.
. . doi:10.1001/jamaneurol.2016.5076 · curator_source · 10.1001/jamaneurol.2016.5076
conditions
Provenance
source title
. . doi:10.1001/jamaneurol.2016.5076
doi
10.1001/jamaneurol.2016.5076
authors
reviewer:will-blair-bot
Gantenerumab subcutaneous dosing reduces brain amyloid in prodromal AD in a dose-dependent manner; a Phase II extension study demonstrated near-complete amyloid clearance at higher doses, informing the dose selection for the Phase III trials.
vs_9fe1d1f2b8ba33b2 · source:. . doi:10.1001/jamaneurol.2016.5076|section:curator_source · manual_curation
outgoing
No outgoing links.
incoming
No incoming links.
events
vev_080ad2b24c0467definding.assertedManual finding added to frontier state
reviewer:will-blair-bot · 2026-05-06
reviewable changes
vpr_dcfc49f1d3d56d1dfinding.addManual finding added to frontier state
applied · reviewer:will-blair-bot · 2026-05-06
evaluations
No evaluation record targets this finding id.